Potential health promotion benefits of lipid testing for all patients presenting with chest pain to an emergency department

Emergency Medicine Journal

Volumn 23, Issue 1, 2006, Pages 23-26

  Elder, C V ^a   Kerr, Debbie ^a   Davey, R X ^b   Kelly, A M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WESTERN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; AUSTRALIA; DYSLIPIDEMIA; EMERGENCY WARD; FEMALE; HEALTH PROMOTION; HEART MUSCLE ISCHEMIA; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH PROMOTION; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MASS SCREENING; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RISK FACTORS; VICTORIA;

EID: 30344488408     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2004.023184     Document Type: Article

References (12)

1. Australian Institute of Health and Welfare 2002. Australia's Health 2002. Canberra: Australian Institute of Health and Welfare, 2002:9-118.
2. National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand. Lipid management guidelines - 2001. Med J Aust 2001;175(suppl):S57-S85.
3. McElduff P, Dobson AJ, Jamrozik K, et al. Opportunities for control of coronary heart disease in Australia. Aust N Z J Public Health 2001 Feb; 25:24-30.
4. Burns RB, Stoy DB, Feied CF, et al. Cholesterol screening the emergency department. J Gen Intern Med 1991;6:210-15.
5. Diercks DB, Kirk JD, Turnipseed SD, et al. Cholesterol screening in an ED-Based chest pain unit. Am J Emerg Med 2002;20:510-12.
6. Chandra A, Compton S, Sochor M, et al. Untreated hypercholesterolemia in an emergency department chest pain observation unit population. Acad Emerg Med 2002;9:699-702.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
8. Bhatnagar D, Durrington PN. Measurement and clinical significance of apolipoproteins A-1 and B. In: Rifai N, Warnick GR, Dominczak MH, eds. Handbook or lipoprotein testing, 2nd edn. Washington DC: American Association for Clinical Chemistry, 2000:287-310.
9. National Cholesterol Education Program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994;89:1333-445.
10. Reinhart RA, Gani K, Arndt MR, et al. Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. Arch Intern Med 1990;150:1629-33.
11. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab), In: Dunstan D, ed. Diabesity and associated disorders in Australia - 2000: the accelerating epidemic. Melbourne: International Diabetes Institute, 2001.
12. Royal Australian College of General Practitioners. National Preventive and Community Medicine Committee. Guidelines for preventive activities in general practice. Aust Fam Physician 2001;30(special issue):S1-S61.